Evaluation of Indiana’s Prescription Drug Monitoring Program: Physician’s Perceptions |Biomedgrid

Prescription Drug Monitoring Programs (PDMPs) [1] are state funded databases that collect data on prescription output of controlled substances. Currently, 49 states within the U.S. have active databases. These databases were implemented as a response to the opioid epidemic, which was caused by an overproduction of opioids. This surplus of addictive medication resulted in physicians prescribing large and often unnecessary amounts of the opioids to individuals who needed pain management [2]. In 1994, Indiana started a form of PDMP known as the Indiana Scheduled Prescription Electronic Collection and Tracking (INSPECT) [3]. At that time only Schedule II drugs were reported using the electronic system. In 2004 it was expanded to Schedule II to V drugs. Currently, Schedule II to V controlled substances along with pseudoephedrine drugs are reported. Included in the reporting is physicians dispensing more than a 72-hour supply out of their office.